Blum Robert I reported option exercise involving 7,500 shares of CYTOKINETICS INC at $10.60 for $79.5k on Sep 28, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
President & CEO
President & CEO
Filed Sep 28, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$79,500Shares × reported price
Shares traded
7,500Common Stock
Price per share
$10.60Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
286,044Direct
Trade date
Sep 28, 2026Option exercise
Filed
Sep 28, 2026, 4:54 PM ET0-day reporting delay
Accession
0001061983-26-000097Code M · Transaction 230487
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 28, 2026Sell7,500$65.46−$490,950Trade 230488
Sep 28, 2026Option exercise7,500$0.00$0Trade 230489
3 transaction rows in this filing. Joint filers share the same rows.

CYTK price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CYTK · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +9%1w ago +2.1%1d ago −2.3%
Returns since7d −5.2%30d −7.4%90d180d1y

Footnotes in full

F1: Shares held by The Bridget Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares. F2: Shares held by The Brittany Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.